ABSTRACT
In this chapter, we shall consider the regulatory issues that impact upon and either facilitate or hinder drug development, especially as it approaches clinical trials. Although this book has pointed out the primacy of allowing a project to be market driven, compliance with regulatory requirements is, of course, one of the key issues in obtaining an acceptable dossier in good time.
